Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

NCT07382505 · clinicaltrials.gov ↗

NOT_YET_RECRUITING

Status

600

Enrollment

OTHER

Sponsor class

Conditions

Uterine Neoplasms
Cervical Cancer

Interventions

GENETIC: Serial blood collection for MRD testing

Sponsor

Asan Medical Center